Circulating miRNA signatures to predict recurrence in patients with pathological complete response of triple-negative breast cancer

被引：0
|
作者：
de Freitas, A. J. A. [1 ]
Nunes, C. R. [2 ]
Causin, R. L. [2 ]
Calfa, S. [1 ]
de Oliveira, M. A. [3 ]
de Padua Souza, C. [4 ]
Marques, M. M. C. [1 ]
机构：
[1] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil
[2] Barretos Canc Hosp, Ctr Oncol Mol, Barretos, Brazil
[3] Barretos Canc Hosp, Nucleus Epidemiol & Biostat, Sao Paulo, Brazil
[4] Hosp Amor, Oncol Dept, Fundacao Pio XII, Hosp Canc Barretos, Barretos, SP, Brazil
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
49P
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [41] Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets
    Zhang, Ying
    You, Chao
    Pei, Yuchen
    Yang, Fan
    Li, Daqiang
    Jiang, Yi-zhou
    Shao, Zhimin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [42] The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure
    Jebbink, M.
    van Werkhoven, E.
    Mandjes, I. A. M.
    Wesseling, J.
    Lips, E. H.
    Peeters, M. -J. T. D. F. Vrancken
    Loo, C. E.
    Sonke, G. S.
    Linn, S. C.
    Falo Zamora, C.
    Rodenhuis, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 145 - 152
  • [43] The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure
    M. Jebbink
    E. van Werkhoven
    I. A. M. Mandjes
    J. Wesseling
    E. H. Lips
    M.-J. T. D. F. Vrancken Peeters
    C. E. Loo
    G. S. Sonke
    S. C. Linn
    C. Falo Zamora
    S. Rodenhuis
    Breast Cancer Research and Treatment, 2015, 153 : 145 - 152
  • [44] Pathological characteristics, distant recurrence rates, and survival outcomes of breast cancer with triple-negative phenotype
    Lee, C. K.
    Choo, E.
    Lewis, C. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response
    Lejeune, Marylene
    Reverte, Laia
    Sauras, Esther
    Gallardo, Noelia
    Bosch, Ramon
    Roso, Albert
    Petit, Anna
    Peg, Vicente
    Riu, Francisco
    Garcia-Fontgivell, Joan
    Ibanez, Jose
    Relea, Fernanda
    Vieites, Begona
    Bor, Catherine
    de la Cruz-Merino, Luis
    Arenas, Meritxell
    Rodriguez, Valerie
    Galera, Juana
    Korzynska, Anna
    Belhomme, Philippe
    Plancoulaine, Benoit
    alvaro, Tomas
    Lopez, Carlos
    CANCERS, 2023, 15 (03)
  • [46] Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
    Sakuma, Kaori
    Kurosumi, Masafumi
    Oba, Hanako
    Kobayashi, Yasuhito
    Takei, Hiroyuki
    Inoue, Kenichi
    Tabei, Toshio
    Oyama, Tetsunari
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (02) : 257 - 264
  • [47] Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patients
    Niedzwiecki, Sebastian
    Piekarski, Janusz
    Szymanska, Bozena
    Pawlowska, Zofia
    Jeziorski, Arkadiusz
    GINEKOLOGIA POLSKA, 2018, 89 (08) : 414 - 419
  • [48] A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer
    Stewart, Rachel L.
    Updike, Katherine L.
    Factor, Rachel E.
    Henry, N. Lynn
    Boucher, Kenneth M.
    Bernard, Philip S.
    Varley, Katherine E.
    CANCER RESEARCH, 2019, 79 (13) : 3466 - 3478
  • [49] Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer
    Zhang, Guojing
    Xie, Wanqing
    Liu, Zhaozhe
    Lin, Chao
    Piao, Ying
    Xu, Long
    Guo, Fang
    Xie, Xiaodong
    TUMORI JOURNAL, 2014, 100 (02): : 136 - 142
  • [50] Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
    Weng, Zeng-Jie
    Wu, Sheng-Xi
    Luo, He-San
    Du, Ze-Sen
    Li, Xu-Yuan
    Lin, Jia-Zhou
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2021, 58
12345